Who
Roger Michael Gendreau
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Dogwood Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jan 2021
- Last trade
- 5 Mar 2026
- Last filed
- 6 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Mar 2026filed 6 Mar 2026 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —82,500 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —82,500 at $0.00 | filing |
| 4 Dec 2025filed 5 Dec 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,075 at $0.00 | filing |
| 26 Feb 2024filed 28 Feb 2024 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —88,085 at $0.00 | filing |
| 12 Dec 2022filed 14 Dec 2022 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 23 Jun 2022filed 30 Jun 2022 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 1 Jan 2021filed 12 Jan 2021 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,734 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.